Nalidixic acid sodium salt CAS:3374-05-8
Nalidixic acid sodium salt is typically administered orally according to the prescribed dosage and frequency provided by a healthcare provider. Patients with urinary tract infections caused by susceptible bacteria, including Escherichia coli, may benefit from treatment with this antibiotic. It is essential to take the medication as directed, usually multiple times a day, with or without food. Before initiating therapy with nalidixic acid sodium salt, healthcare providers may conduct susceptibility testing to ensure its effectiveness against the specific bacterial strain causing the infection. Patients should complete the full course of treatment even if symptoms improve to prevent relapse or the development of antibiotic resistance. Monitor for any adverse effects while taking nalidixic acid sodium salt, such as gastrointestinal disturbances or hypersensitivity reactions, and promptly report any concerns to a healthcare professional. Adequate hydration during treatment can help support kidney function and optimize drug clearance. Proper storage of the medication in a cool, dry place away from moisture and sunlight is essential to maintain its efficacy. Consulting a healthcare provider for guidance on the appropriate use of nalidixic acid sodium salt is recommended to ensure effective management of urinary tract infections and minimize the risk of complications associated with bacterial resistance.
Composition | C12H13N2NaO3 |
Assay | 99% |
Appearance | white powder |
CAS No. | 3374-05-8 |
Packing | Small and bulk |
Shelf Life | 2 years |
Storage | Store in cool and dry area |
Certification | ISO. |